These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32563776)

  • 1. Cannabis use the week before admission to psychiatric in-patient service as a marker of severity.
    Madero S; Oliveras C; Pons MT; Sague M; López-Pelayo H; Gual A; Balcells M
    J Psychiatr Res; 2020 Oct; 129():40-46. PubMed ID: 32563776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study.
    Teetharatkul T; Vitayanont A; Liabsuetrakul T; Aunjitsakul W
    BMC Psychiatry; 2021 Jul; 21(1):348. PubMed ID: 34253169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals.
    Geffen J; Sorensen L; Stokes J; Cameron A; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):649-56. PubMed ID: 12225449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of cannabis use on inpatient psychiatric hospital outcomes.
    Rylander M; Winston HR; Medlin H; Hull M; Nussbaum A
    Am J Drug Alcohol Abuse; 2018; 44(1):73-84. PubMed ID: 28613973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
    Díaz-Marsá M; Sánchez S; Rico-Villademoros F;
    J Clin Psychiatry; 2009 Apr; 70(4):509-17. PubMed ID: 19358789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of clinical response in schizophrenia patients receiving the atypical antipsychotic zotepine.
    Lin CH; Chou LS; Lin CH; Hsu CY; Chen YS; Lane HY
    J Clin Psychiatry; 2007 Oct; 68(10):1522-7. PubMed ID: 17960966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
    Howard R; Cort E; Bradley R; Harper E; Kelly L; Bentham P; Ritchie C; Reeves S; Fawzi W; Livingston G; Sommerlad A; Oomman S; Nazir E; Nilforooshan R; Barber R; Fox C; Macharouthu A; Ramachandra P; Pattan V; Sykes J; Curran V; Katona C; Dening T; Knapp M; Romeo R; Gray R
    Health Technol Assess; 2018 Nov; 22(67):1-62. PubMed ID: 30507375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Brief Psychiatric Rating Scale as an acute inpatient outcome measurement tool: a pilot study.
    Varner RV; Chen YR; Swann AC; Moeller FG
    J Clin Psychiatry; 2000 Jun; 61(6):418-21. PubMed ID: 10901339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.
    Takahashi H; Kamata M; Yoshida K; Ishigooka J; Higuchi H
    J Clin Psychiatry; 2006 Oct; 67(10):1577-82. PubMed ID: 17107250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study.
    Alvarez E; Bobes J; Gómez JC; Sacristán JA; Cañas F; Carrasco JL; Gascón J; Gibert J; Gutiérrez M;
    Eur Neuropsychopharmacol; 2003 Jan; 13(1):39-48. PubMed ID: 12480121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
    Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
    Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
    J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
    Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Brief Psychiatric Rating Scale to facilitate differential diagnosis at acute inpatient admission.
    Hopko DR; Averill PM; Small D; Greenlee H; Varner RV
    J Clin Psychiatry; 2001 Apr; 62(4):304-12; quiz 313-4. PubMed ID: 11379850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
    Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
    Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severely psychotic inpatients with schizophrenia: olanzapine versus other antipsychotic drugs.
    Carrasco JL; Gutiérrez M; Gómez JC; Escobar R; Alvarez E; Cañas F; Bobes J; Gascón J; Gibert J
    Int Clin Psychopharmacol; 2002 Nov; 17(6):287-95. PubMed ID: 12409682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay.
    Johnson JM; Wu CY; Winder GS; Casher MI; Marshall VD; Bostwick JR
    J Dual Diagn; 2016; 12(3-4):244-251. PubMed ID: 27710762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supporting Future Cannabis Policy - Developing a Standard Joint Unit: A Brief Back-Casting Exercise.
    López-Pelayo H; Matrai S; Balcells-Olivero M; Campeny E; Braddick F; Bossong MG; Cruz OS; Deluca P; Dom G; Feingold D; Freeman TP; Guzman P; Hindocha C; Kelly BC; Liebregts N; Lorenzetti V; Manthey J; Matias J; Oliveras C; Pons MT; Rehm J; Rosenkranz M; Swithenbank Z; van Deurse L; Vicente J; Vuolo M; Wojnar M; Gual A
    Front Psychiatry; 2021; 12():675033. PubMed ID: 34093282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.